Chae-Ok Yun,
Professor, Department of Bioengineering
Chae-Ok Yun is currently a Professor of Bioengineering at Hanyang University, Seoul, Korea. She is also an Adjunct Professor of Pharmaceuticals and Pharmaceutical Chemistry at University of Utah, United States, an Affiliate Professor of Medicine at University of Washington, United States, a Guest Professor of Sichuan University, China, and an Adjunct Professor of Genomics at Yonsei University, Korea. She has served as Deputy Editor of Molecular Therapy (2010-), Associate Editor of BMC Cancer (2010-) and Cancer Gene Therapy (2013-), Editorial Board member of Journal of Controlled Release (2010-), Gene Therapy and Regulation (2010-), International Journal of Cancer Research & Diagnosis (2013-), Regenerative Therapy (2016-), and Advanced Drug Delivery Review (2016-), an Associate Editor in Chief of Oncolytic Virotherapy (2017-), and an Editorial Advisor of BMC Biomedical Engineering. She is also a Member of The National Academy of Engineering of Korea. She was awarded the Excellence in Research Award from American Society of Gene Therapy in 2002 and Excellent Professor in Research Achievement from Yonsei University in 2003, 2005, 2007, 2008, and 2011. She received the Bowon Award for Best Research Activity from Yonsei University in 2007. She also was awarded the Excellence in Research Award from Korean Society of Gene Therapy (2011, 2012, and 2014), Korean Government Ministry award from Ministry of Science (2013), LG Yonam Foundation (2016), and International Society of Cancer Gene Therapy (2016). Her research interests include cancer gene therapy, immunotherapy, angiogenesis, combination of viral vectors and non-viral vectors, nanomedicine, and tumor biology. One of her gene therapeutics is in clinical trial against cancer patients.
|
|
